Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline
about
Engineering protein thermostability using a generic activity-independent biophysical screen inside the cellA tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activitiesThe molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β.AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1.The Role of Interleukin-1 in Inflammatory and Malignant Human Skin Diseases and the Rationale for Targeting Interleukin-1 Alpha.A comparative analysis of the properties of regulated promoter systems commonly used for recombinant gene expression in Escherichia coli.Structural and thermodynamic effects of ANS binding to human interleukin-1 receptor antagonist.High-pressure studies of aggregation of recombinant human interleukin-1 receptor antagonist: thermodynamics, kinetics, and application to accelerated formulation studies.Multistep aggregation pathway of human interleukin-1 receptor antagonist: kinetic, structural, and morphological characterization.SnapDock-template-based docking by Geometric Hashing.High concentration formulations of recombinant human interleukin-1 receptor antagonist: I. Physical characterization.Evaluating the autoinduction expression system and one-step purification for high-level expression and purification of gallbladder-derived rhIL-1Ra.
P2860
Q27687991-E396D86A-79F0-475C-93AA-87B3C319723CQ28138555-5EC91C0A-F35D-4D82-8DAE-664ADD39DF1FQ34489972-79DC88AB-09B3-4F80-AE49-F70E65004DEEQ36835021-02DF9CAC-08F5-4468-B481-95E1858AE94EQ38948602-275450BE-F9E3-4E6C-9049-69E5A815E673Q39716696-F6A10EB1-84A7-451A-823C-507F7442388EQ42225236-0D471F07-3F61-4F3C-B5FE-4D3492641955Q43058115-8E667266-0C91-4659-8FAC-F1371D224B19Q43094653-5579D8C8-2884-4702-BFF3-D60ED34DC2ECQ47322436-A0910BEF-3AF7-4FC4-A627-35A6C75BE552Q50873904-8B18AEF1-7D33-4043-92CA-A75C0184418CQ50906970-C013EA2C-E249-4FF7-93AD-9DE4DD767DE7
P2860
Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline
description
1995 nî lūn-bûn
@nan
1995 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Refined crystal structure of t ...... sulfide link and a cis-proline
@ast
Refined crystal structure of t ...... sulfide link and a cis-proline
@en
Refined crystal structure of t ...... sulfide link and a cis-proline
@nl
type
label
Refined crystal structure of t ...... sulfide link and a cis-proline
@ast
Refined crystal structure of t ...... sulfide link and a cis-proline
@en
Refined crystal structure of t ...... sulfide link and a cis-proline
@nl
prefLabel
Refined crystal structure of t ...... sulfide link and a cis-proline
@ast
Refined crystal structure of t ...... sulfide link and a cis-proline
@en
Refined crystal structure of t ...... sulfide link and a cis-proline
@nl
P2093
P2860
P1433
P1476
Refined crystal structure of t ...... sulfide link and a cis-proline
@en
P2093
A Soffientini
H A Schreuder
J M Rondeau
R W Barrett
S Yanofsky
T L Bowlin
P2860
P304
P356
10.1111/J.1432-1033.1995.TB20209.X
P407
P577
1995-02-01T00:00:00Z